Ligand-specific control of src-suppressed C kinase substrate gene expression

Biochemical and Biophysical Research Communications

Volumn 297, Issue 5, 2002, Pages 1112-1120

  Coats, Stephen R ^a   Pabón Pea, Lil M ^a   Covington, Joseph W ^a   Vaughan, Douglas E ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adhesion; EPA; LPA; Morphology; NaB; PDGF BB; SSeCKS

Indexed keywords

BUTYRIC ACID; ICOSAPENTAENOIC ACID; LIGAND; LYSOPHOSPHATIDIC ACID; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE C; SRC SUPPRESSED C KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL SPREADING; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME SUBSTRATE; FIBROBLAST; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOCYTOCHEMISTRY; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SMOOTH MUSCLE FIBER;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE, TRANSFORMED; CELLS, CULTURED; CLONING, MOLECULAR; DOSE-RESPONSE RELATIONSHIP, DRUG; EICOSAPENTAENOIC ACID; FIBROBLASTS; IMMUNOHISTOCHEMISTRY; LIGANDS; LYSOPHOSPHOLIPIDS; MICROSCOPY, FLUORESCENCE; MITOGENS; MUSCLE, SMOOTH; PLATELET-DERIVED GROWTH FACTOR; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RATS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SODIUM OXYBATE; TIME FACTORS; UP-REGULATION;

EID: 0036401167     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02275-1     Document Type: Article

References (53)

1. X. Lin, E. Tombler, P.J. Nelson, M. Ross, I.H. Gelman, A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture, J. Biol. Chem. 271 (1996) 28430-28438.
2. X. Lin, I.H. Gelman, Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis, Cancer Res. 57 (1997) 2304-2312.
3. C. Chapline, J. Cottom, H. Tobin, J. Hulmes, J. Crabb, S. Jaken, A major, transformation-sensitive PKC-binding protein is also a PKC substrate involved in cytoskeletal remodeling, J. Biol. Chem. 273 (1998) 19482-19489.
4. I.H. Gelman, K. Lee, E. Tombler, R. Gordon, X. Lin, Control of cytoskeletal architecture by the src-suppressed C kinase substrate, SSeCKS, Cell Motil. Cytoskeleton 41 (1998) 1-17.
5. P.J. Nelson, K. Moissoglu, J. Vargas, P.E. Klotman, I.H. Gelman, Involvement of the protein kinase C substrate, SSeCKS, in the actin-based stellate morphology of mesangial cells, J. Cell Sci. 112 (3) (1999) 361-370.
6. X. Lin, P.J. Nelson, B. Frankfort, E. Tombler, R. Johnson, I.H. Gelman, Isolation and characterization of a novel mitogenic regulatory gene, 322, which is transcriptionally suppressed in cells transformed by src and ras, Mol. Cell. Biol. 15 (1995) 2754-2762.
7. P.J. Nelson, I.H. Gelman, Cell-cycle regulated expression and serine phosphorylation of the myristylated protein kinase C substrate, SSeCKS: correlation with culture confluency, cell cycle phase and serum response, Mol. Cell. Biochem. 175 (1997) 233-241.
8. X. Lin, P. Nelson, I.H. Gelman, SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1) → S progression by controlling the expression and cellular compartmentalization of cyclin D, Mol. Cell. Biol. 20 (2000) 7259-7272.
9. S.R. Coats, J.W. Covington, M. Su, L.M. Pabon-Pena, M. Eren, Q. Hao, D.E. Vaughan, SSeCKS gene expression in vascular smooth muscle cells: regulation by angiotensin II and a potential role in the regulation of PAI-1 gene expression, J. Mol. Cell. Cardiol. 32 (2000) 2207-2219.
10. X. Lin, I.H. Gelman, Calmodulin and cyclin D anchoring sites on the src-suppressed C kinase substrate SSeCKS, Biochem. Biophys. Res. Commun. 290 (2002) 1368-1375.
11. M.J. Wassler, C.I. Foote, I.H. Gelman, B.D. Shur, Functional interaction between the SSeCKS scaffolding protein and the cytoplasmic domain of β1,4-galactosyltransferase, J. Cell Sci. 114 (2001) 2291-2300.
12. J.B. Nauert, T.M. Klauck, L.K. Langeberg, J.D. Scott, Gravin, an autoantigen recognized by serum from myasthenia gravis patients, is a kinase scaffold protein, Curr. Biol. 7 (1997) 52-62.
13. J. Erlichman, R. Gutierrez-Juarez, S. Zucker, X. Mei, G.A. Orr, Developmental expression of the protein kinase C substrate/binding protein (clone 72/SSeCKS) in rat testis identification as a scaffolding protein containing an A-kinase-anchoring domain which is expressed during late-stage spermatogenesis, Eur. J. Biochem. 263 (1999) 797-805.
14. H. Kitamura, K. Okita, D. Fujikura, K. Mori, T. Iwanaga, M. Saito, Induction of src-suppressed C kinase substrate (SSeCKS) in vascular endothelial cells by bacterial lipopolysaccharide, J. Histochem. Cytochem. 50 (2002) 245-255.
15. G.R. Grotendorst, H.E. Seppa, H.K. Kleinman, G.R. Martin, Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor, Proc. Natl. Acad. Sci. USA 78 (1981) 3669-3672.
16. G. Liu, E. Espinosa, B.S. Oemar, T.F. Luscher, Bimodal effects of angiotensin II on migration of human and rat smooth muscle cells. Direct stimulation and indirect inhibition via transforming growth factor-β 1, Arterioscler. Thromb. Vasc. Biol. 17 (1997) 1251-1257.
17. M.C. Riedy, M.C. Brown, C.J. Molloy, C.E. Turner, Activin A and TGF-β stimulate phosphorylation of focal adhesion proteins and cytoskeletal reorganization in rat aortic smooth muscle cells, Exp. Cell Res. 251 (1999) 194-202.
18. M. Mizutani, M. Asano, S. Roy, T. Nakajima, M. Soma, K. Yamashita, Y. Okuda, Omega-3 polyunsaturated fatty acids inhibit migration of human vascular smooth muscle cells in vitro, Life Sci. 61 (1997) L269-L274.
19. M. Nakayama, N. Fukuda, Y. Watanabe, M. Soma, W.Y. Hu, H. Kishioka, C. Satoh, A. Kubo, K. Kanmatsuse, Low dose of eicosapentaenoic acid inhibits the exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats through suppression of transforming growth factor-β, J. Hypertens. 17 (1999) 1421-1430.
20. R.H. Weiss, A.P. Yabes, R. Sinaee, TGF-β and phorbol esters inhibit mitogenesis utilizing parallel protein kinase C-dependent pathways, Kidney Int. 48 (1995) 738-744.
21. B.S. Dixon, M.J. Dennis, Regulation of mitogenesis by kinins in arterial smooth muscle cells, Am. J. Physiol. 273 (1997) C7-C20.
22. S.L. Connor, W.E. Connor, Are fish oils beneficial in the prevention and treatment of coronary artery disease?, Am. J. Clin. Nutr. 66 (1997) 1020S-1031S.
23. D.N. Kim, A. Eastman, J.E. Baker, A. Mastrangelo, S. Sethi, J.S. Ross, J. Schmee, W.A. Thomas, Fish oil, atherogenesis, and thrombogenesis, Ann. NY Acad. Sci. 748 (1995) 474-480.
24. E.S. Collie-Duguid, K.W. Wahle, Inhibitory effect of fish oil N-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules, Biochem. Biophys. Res. Commun. 220 (1996) 969-974.
25. T. Ishida, M. Ishida, J. Suero, M. Takahashi, B.C. Berk, Agonist-stimulated cytoskeletal reorganization and signal transduction at focal adhesions in vascular smooth muscle cells require c-src, J. Clin. Invest. 103 (1999) 789-797.
26. K. Kappert, G. Schmidt, G. Doerr, B. Wollert-Wulf, E. Fleck, K. Graf, Angiotensin II and PDGF-BB stimulate β(1)-integrin-mediated adhesion and spreading in humanVSMCs, Hypertension 35 (2000) 255-261.
27. J.S. Karliner, Lysophospholipids and the cardiovascular system, Biochim. Biophys. Acta 1582 (2002) 216-221.
28. S. Ai, M. Kuzuya, T. Koike, T. Asai, S. Kanda, K. Maeda, T. Shibata, A. Iguchi, Rho-Rho kinase is involved in smooth muscle cell migration through myosin light chain phosphorylation-dependent and independent pathways, Atherosclerosis 155 (2001) 321-327.
29. U. Schmitz, K. Thommes, I. Beier, H. Vetter, Lysophosphatidic acid stimulates p21-activated kinase in vascular smooth muscle cells, Biochem. Biophys. Res. Commun. 291 (2002) 687-691.
30. I.H. Gelman, E. Tombler, J. Vargas, A role for SSeCKS, a major protein kinase C substrate with tumour suppressor activity, in cytoskeletal architecture, formation of migratory processes, and cell migration during embryogenesis, Histochem. J. 32 (2000) 13-26.
31. S.E. Egan, J.A. Wright, L. Jarolim, K. Yanagihara, R.H. Bassin, A.H. Greenberg, Transformation by oncogenes encoding protein kinases induces the metastatic phenotype, Science 238 (1987) 202-205.
32. M.P. Ryan, P.J. Higgins, Cytoarchitecture of Kirsten sarcoma virus-transformed rat kidney fibroblasts: butyrate-induced reorganization within the actin microfilament network, J. Cell. Physiol. 137 (1988) 25-34.
33. M.P. Ryan, P.J. Higgins, Sodium-n-butyrate induces secretion and substrate accumulation of p52 in Kirsten sarcoma virus-transformed rat kidney fibroblasts, Int. J. Biochem. 21 (1989) 31-37.
34. P.J. Higgins, M.P. Ryan, Cytoarchitecture of ras oncogene-expressing tumor cells: butyrate modulation of substrate adhesion, cytoskeletal actin content and subcellular microfilament distribution, Int. J. Biochem. 21 (1989) 1143-1151.
35. P.J. Higgins, M.P. Ryan, R. Zeheb, T.D. Gelehrter, P. Chaudhari, p52 induction by cytochalasin D in rat kidney fibroblasts: homologies between p52 and plasminogen activator inhibitor type-1, J. Cell. Physiol. 143 (1990) 321-329.
36. P.J. Higgins, M.P. Ryan, p52(PAI-1) and actin expression in butyrate-induced flat revertants of v-ras-transformed rat kidney cells, Biochem. J. 279 (Pt 3) (1991) 883-890.
37. P.J. Higgins, M.P. Ryan, D.M. Jelley, P52PAI-1 gene expression in butyrate-induced flat revertants of v-ras-transformed rat kidney cells: mechanism of induction and involvement in the morphological response, Biochem. J. 321 (Pt 2) (1997) 431-437.
38. Y. Kubohara, K. Hosaka, The putative morphogen, DIF-1, of dictyostelium discoideum activates Akt/PKB in human leukemia K562 cells, Biochem. Biophys. Res. Commun. 263 (1999) 790-796.
39. Y. Miwa, T. Sasaguri, C. Kosaka, Y. Taba, A. Ishida, T. Abumiya, Y. Kubohara, Differentiation-inducing factor-1, a morphogen of dictyostelium, induces G(1) arrest and differentiation of vascular smooth muscle cells, Circ. Res. 86 (2000) 68-75.
40. P.A. Appeddu, B.D. Shur, Control of stable lamellipodia formation by expression of cell surface β1,4-galactosyltransferase cytoplasmic domains, J. Cell Sci. 107 (9) (1994) 2535-2545.
41. W. Xia, I.H. Gelman, Mitogen-induced FAK-dependent tyrosine phosphorylation of the SSECKS scaffolding protein, Exp. Cell Res. 277 (2002) 139-151.
42. M. Shih, F. Lin, J.D. Scott, H.Y. Wang, C.C. Malbon, Dynamic complexes of β2-adrenergic receptors with protein kinases and phosphatases and the role of gravin, J. Biol. Chem. 274 (1999) 1588-1595.
43. F. Lin, H. Wang, C.C. Malbon, Gravin-mediated formation of signaling complexes in β2-adrenergic receptor desensitization and resensitization, J. Biol. Chem. 275 (2000) 19025-19034.
44. H.M. Rosenfeldt, J.P. Hobson, S. Milstien, S. Spiegel, The sphingosine-1-phosphate receptor EDG-1 is essential for platelet-derived growth factor-induced cell motility, Biochem. Soc. Trans. 29 (2001) 836-839.
45. M. Goppelt-Struebe, S. Fickel, C.O. Reiser, The platelet-derived-growth-factor receptor, not the epidermal-growth-factor receptor, is used by lysophosphatidic acid to activate p42/44 mitogen-activated protein kinase and to induce prostaglandinG/H synthase-2 in mesangial cells, Biochem. J. 345 (2) (2000) 217-224.
46. X. Fang, S. Yu, J.L. Tanyi, Y. Lu, J.R. Woodgett, G.B. Mills, Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway, Mol. Cell. Biol. 22 (2002) 2099-2110.
47. K. Hayashi, H. Saga, Y. Chimori, K. Kimura, Y. Yamanaka, K. Sobue, Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase, J. Biol. Chem. 273 (1998) 28860-28867.
48. K. Hayashi, M. Takahashi, W. Nishida, K. Yoshida, Y. Ohkawa, A. Kitabatake, J. Aoki, H. Arai, K. Sobue, Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids, Circ. Res. 89 (2001) 251-258.
49. E.P. Candido, R. Reeves, J.R. Davie, Sodium butyrate inhibits histone deacetylation in cultured cells, Cell 14 (1978) 105-113.
50. L. Cuisset, L. Tichonicky, P. Jaffray, M. Delpech, The effects of sodium butyrate on transcription are mediated through activation of a protein phosphatase, J. Biol. Chem. 272 (1997) 24148-24153.
51. K. Kim, J. Cai, S. Shuja, T. Kuo, M.J. Murnane, Presence of activated ras correlates with increased cysteine proteinase activities in human colorectal carcinomas, Int. J. Cancer 79 (1998) 324-333.
52. M. Demoz, R. Castino, A. Dragonetti, E. Raiteri, F.M. Baccino, C. Isidoro, Transformation by oncogenic ras-p21 alters the processing and subcellular localization of the lysosomal protease cathepsin D, J. Cell. Biochem. 73 (1999) 370-378.
53. A. Camus, K. Mesbah, M. Rallu, C. Babinet, J. Barra, Gene trap insertion reveals two open reading frames in the mouse SSeCKS gene: the form predominantly detected in the nervous system is suppressed by the insertion while the other, specific of the testis, remains expressed, Mech. Dev. 105 (2001) 79-91.